EMFAT
AXSM icon

Emerald Mutual Fund Advisers Trust’s Axsome Therapeutics AXSM Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.4M Buy
67,195
+141
+0.2% +$30.6K 0.58% 79
2026
Q1 		$11.3M Sell
67,054
-554
-0.8% -$95.7K 0.55% 75
2025
Q4 		$12.3M Buy
67,608
+2,103
+3% +$294K 0.6% 76
2025
Q3 		$7.96M Buy
65,505
+1,570
+2% +$177K 0.41% 90
2025
Q2 		$6.67M Buy
+63,935
New +$6.77M 0.41% 91

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's AXSM Position: Q2 2026 in Review

Emerald Mutual Fund Advisers Trust increased its Axsome Therapeutics (AXSM) stake by 0.21% in Q2 2026, buying an estimated $30.6K and bringing the position to 67,195 shares worth $16.4M. The position accounts for 0.58% of the portfolio, ranked #79.

Emerald Mutual Fund Advisers Trust first reported a position in AXSM in Q2 2025 and has held it in 5 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Emerald Mutual Fund Advisers Trust held 67,195 shares of Axsome Therapeutics worth $16.4M as of Q2 2026.
  • Emerald Mutual Fund Advisers Trust bought 141 Axsome Therapeutics shares in Q2 2026, an estimated $30.6K.
  • Axsome Therapeutics made up 0.58% of Emerald Mutual Fund Advisers Trust's portfolio in Q2 2026, its #79 holding.
  • Emerald Mutual Fund Advisers Trust first reported a position in Axsome Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2026, filed 5 Aug 2026.